<div id="readability-page-1"><p>HCR Wealth Advisors lessened its stake in  AMETEK, Inc. (NYSE:AME - Free Report) by 7.9% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor  owned 86,622 shares of the technology company's stock after selling 7,410 shares during the quarter. AMETEK makes up  about  1.7% of HCR Wealth Advisors' portfolio, making the stock its 11th biggest holding. HCR Wealth Advisors' holdings in AMETEK were worth $16,123,000 as of its most recent filing with the SEC.</p><ul><li>Industrials Shine As Ametek, Cintas, Eaton Trade At New Highs</li></ul><p>Other institutional investors and hedge funds have also modified their holdings of the company. GAMMA Investing LLC lifted its stake in  AMETEK by 15.4% in the 3rd quarter. GAMMA Investing LLC now owns 6,269 shares of the technology company's stock valued at $1,179,000 after buying an additional 835 shares in the last quarter.  Praxis Investment Management Inc. raised its holdings in shares of  AMETEK by 33.9% during the third quarter. Praxis Investment Management Inc. now owns 5,355 shares of the technology company's stock valued at $1,007,000 after acquiring an additional 1,355 shares during the last quarter.  Osaic Holdings Inc. lifted its position in shares of  AMETEK by 11.7% in the second quarter. Osaic Holdings Inc. now owns 16,997 shares of the technology company's stock valued at $3,077,000 after acquiring an additional 1,775 shares in the last quarter.  Total Investment Management Inc. acquired a new stake in shares of  AMETEK in the second quarter worth approximately $126,000.  Finally, Orion Porfolio Solutions LLC boosted its stake in shares of  AMETEK by 2.1% in the second quarter. Orion Porfolio Solutions LLC now owns 19,809 shares of the technology company's stock worth $3,585,000 after acquiring an additional 415 shares during the last quarter. Hedge funds and other institutional investors own  87.43% of the company's stock. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of research analysts have weighed in on AME shares. DA Davidson raised their price objective on AMETEK from $235.00 to $240.00 and gave the company a &#34;buy&#34; rating in a report on Monday, December 8th. Barclays increased their target price on shares of AMETEK from $200.00 to $205.00 and gave the company an &#34;equal weight&#34; rating in a research report on Friday, October 31st. Weiss Ratings  restated a &#34;buy (b)&#34; rating on shares of AMETEK in a research report on Wednesday, October 8th. KeyCorp raised their target price on shares of AMETEK from $205.00 to $220.00 and gave the stock an &#34;overweight&#34; rating in a research note on Friday, October 31st. Finally, Robert W. Baird increased their price target on AMETEK from $198.00 to $204.00 and gave the company a &#34;neutral&#34; rating in a report on Monday, November 3rd. Seven research analysts have rated the stock with a Buy rating and six have issued  a Hold rating to the stock. Based on data from MarketBeat.com, AMETEK currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $212.00.</p><p><b>View Our Latest Report on AMETEK</b></p><h2>AMETEK Price Performance</h2><p>NYSE:AME opened at $203.23 on Tuesday. AMETEK, Inc. has a 52 week low of $145.02 and a 52 week high of $204.43. The stock's fifty day moving average is $192.97 and its two-hundred day moving average is $186.31. The company has a market capitalization of $46.78 billion, a P/E ratio of 32.05, a P/E/G ratio of 2.87 and a beta of 1.04. The company has a quick ratio of 0.72, a current ratio of 1.16 and a debt-to-equity ratio of 0.14. </p><p>AMETEK (NYSE:AME - Get Free Report) last issued its quarterly earnings data on Thursday, October 30th. The technology company reported $1.89 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.76 by $0.13. AMETEK had a return on equity of 16.66% and a net margin of 20.50%.The firm had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same period last year, the company earned $1.66 EPS. The company's quarterly revenue was up 10.8% on a year-over-year basis. AMETEK has set its Q4 2025 guidance at 1.900-1.950 EPS and its FY 2025 guidance at 7.320-7.370 EPS.  Equities analysts expect that  AMETEK, Inc. will post 7.15 EPS for the current year. </p><h2>AMETEK Dividend Announcement</h2><p>The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 19th. Investors of record on Friday, December 5th will be given a dividend of $0.31 per share. The ex-dividend date of this dividend is Friday, December 5th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.6%. AMETEK's dividend payout ratio (DPR) is presently 19.56%. </p><h2>Insiders Place Their Bets</h2><p>In related news, insider Ronald J. Oscher sold 26,290 shares of the firm's stock in a transaction that occurred on Friday, October 31st. The shares were sold at an average price of $200.05, for a total value of $5,259,314.50. Following the sale, the insider owned 40,226 shares of the company's stock, valued at $8,047,211.30. This trade represents a 39.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. Also, CEO David A. Zapico sold 28,390 shares of the firm's stock in a transaction on Friday, December 12th. The shares were sold at an average price of $201.76, for a total transaction of $5,727,966.40. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 142,680 shares of company stock valued at $28,269,601 over the last ninety days. Insiders own  0.57% of the company's stock. </p><h2>AMETEK Company Profile</h2> (Free Report)<p>AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.</p><h2>See Also</h2><ul><li>Five stocks we like better than AMETEK</li><li>What Does a Stock Split Mean? </li><li>Pfizer Adds to Its Big Bet on Weight Loss Drugs</li><li>Profitably Trade Stocks at 52-Week Highs</li><li>ServiceNow’s $7 Billion Gamble: Panic or Opportunity?</li><li>How Can Investors Benefit From After-Hours Trading</li><li>Dell and HP Are Raising Prices—And Investors Should Take Note</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFNRQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFNRQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in AMETEK Right Now?</h2><p>Before you consider AMETEK, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.</p><p>While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>HCR Wealth Advisors reduced its stake in AMETEK, Inc. by 7.9% in Q3, now holding 86,622 shares valued at $16.1 million. Other institutional investors like GAMMA Investing LLC and Praxis Investment Management Inc. increased their holdings. AMETEK's stock has a moderate buy rating with a target price of $212.00. The company reported Q3 earnings of $1.89 per share, exceeding estimates, and announced a quarterly dividend of $0.31 per share.</p>

AMETEK, Inc. $AME Shares Sold by HCR Wealth Advisors